• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation (2001); Pericardial Effusion (3271)
Event Date 07/21/2023
Event Type  Injury  
Event Description
It was reported that a pericardial effusion occurred post procedure.It was reported that a versacross connect was selected for use during a watchman left atrium appendage closure, which was completed, with no issues noted during transseptal (it was inferior and posterior).Several hours post procedure, prior to discharge the patient, a pericardial effusion was noted.Thus, a pericardiocentesis was performed.The patient was admitted to hospital beyond standard of care and it has been discarded on (b)(6) 2023.The device is not expected to be returned for analysis.No pe was noted prior to the procedure.No other issues were noted in regards to the transseptal.There is no reason to suspect that they were attributed to versacross connect devices.There was a wire sheath exchange done in the appendage where the versacross wire was briefly exposed out of the pigtail catheter and not fully deployed in its safe loop.This is when boston sales rep believes to be the most likely time for the perforation to have occurred.The physician could not determine which time the perforation actually occurred.The most remarkable part of the procedure was the difficulty getting the pigtail catheter to advance into the appendage.No confirmation of that on the echo or fluoroscopic findings.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17701957
MDR Text Key322879015
Report Number2124215-2023-43631
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/21/2023
Initial Date FDA Received09/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age89 YR
Patient SexMale
-
-